A recent large-scale study indicates that an AI-supported stroke clinical decision support system (CDSS) can enhance patient outcomes by significantly reducing the risk of recurrent vascular events. Conducted in China across 77 hospitals, the trial involved over 21,000 participants experiencing acute ischemic strokes. Those using the AI-driven system saw a 26% reduction in new vascular events at 3 months, compared to standard care. The CDSS analyzed brain scans and provided tailored treatment recommendations based on patient-specific factors. Importantly, this AI tool demonstrated safety without increasing risks of disability or mortality. Despite modest improvements in care quality scores—from 89.8% to 91.4%—certain metrics crucial for secondary prevention showed considerable enhancement. Researchers highlight that the CDSS integrates easily into existing hospital infrastructures, suggesting its potential for sustainable use, especially in resource-limited settings. This study underlines the promise of AI in achieving high-quality stroke care and improving clinical outcomes effectively.
Source link
Share
Read more